Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)
Clinical trial NCT00891462 · COMPLETED
Trial details
- NCT number
- NCT00891462
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2009-11-01
- Enrollment
- 561
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.